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NO• is a free radical and is involved in a number of critical
physiological processes including vasodilation, neurotransmission,
immune regulation and inﬂammation. There are convincing evi-
dence suggesting a role of NO• in the development and progression
of different cancer types. However, the role of NO• in tumorigenesis
is highly complex and both pro- and anti-neoplastic functions have
been reported, which largely depends on the amount of NO•, cell
types, cellular microenvironment, its interaction with other reactive
species and presence of metals. An interesting interaction occurs
between NO• and p53 tumor suppressor, in which NO•-induced
DNA damage causes the stabilization and accumulation of p53,
which in turn, transrepresses inducible nitric oxide synthase (NOS2)
in a negative feedback loop. In chronic inﬂammatory diseases, for
example ulcerative colitis, NO• induces p53 stabilization and the
initiation of DNA-damage response pathway, and also generation of
p53 mutation and subsequent clonal selection of p53 mutant cells.
Genetic deletion of NOS2 in p53-deﬁcient mice can either suppress
or enhance lymphomagenesis depending on the inﬂammatory
microenvironment. These ﬁndings highlight the importance of
understanding the complex biological interaction of NO• in the
context of the molecular makeup of each individual cancer to
design NO•-targeted treatment strategies.
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Inﬂammation generates reactive chemical species that induce
conditions of oxidative nitrosative stress as emerged as factor in
poor outcome of many cancers. Our recent ﬁndings show that in
the inﬂammatory protein inducible nitric oxide synthase (iNOS) is
a strong predictor of poor outcome in ER(-) patients (Glynn et al.
JCI 2010). Furthermore 46 genes, of which 23 were associated with
basal like breast cancer, were elevated when iNOS high. In vitro
studies using ER(-) cell lines showed that ﬂuxes of nitric oxide
(NO) delivered by NO donors surprising mimic this relationship in
the patient cohort. Using this model, we show that NO at different
speciﬁc concentrations stimulate pro-oncogenic mechanisms such
as AKT, ERK, NFkB, AP-1, and HIF-1α that lead to increase of
metastatic and cancer stem cells proteins. In addition, we show
that tumor suppressor gene BRCA1 and PP2A are inhibited by
these NO levels. Similarly other studies show that these concen-
trations of NO increase immunosuppressive proteins TGF-β and IL-
10 in leukocytes to decrease efﬁcacy of some anticancer therapies
further contributing to pro-tumorigenic environment. Using this
model we have identiﬁed several new compounds that have
efﬁcacy in xenographic models. These ﬁnding have provided a
model that shows how NO can affect numerous mechanism that
leads to a more aggressive phenotype.
http://dx.doi.org/10.1016/j.redox.2015.09.012
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/redox
Redox Biology
2213-2317/& 2015 Published by Elsevier B.V.
Redox Biology 5 (2015) 413–423
